Filing Details

Accession Number:
0000899243-18-025318
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-26 18:58:29
Reporting Period:
2018-09-24
Accepted Time:
2018-09-26 18:58:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1631574 Wave Life Sciences Ltd. WVE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657675 Chandra Vargeese C/O Wave Life Sciences Ltd.,
733 Concord Ave.
Cambridge MA 02138
Senior Vp, Drug Discovery No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-09-24 3,000 $2.48 30,300 No 4 M Direct
Ordinary Shares Disposition 2018-09-24 3,000 $55.00 27,300 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Share Option (right to buy) Disposition 2018-09-24 3,000 $0.00 3,000 $2.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
149,542 2025-03-10 No 4 M Direct
Footnotes
  1. The option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.
  2. The incentive share option initially represented a right to purchase a total of 158,042 ordinary shares, 25% of which became exercisable on August 1, 2015, and the remaining shares vest in 36 equal monthly installments thereafter.